Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Concord grape juice increased HDL, lowered inflammatory marker linked to heart disease

17.11.2004


Study presented in the November issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology



Drinking Concord grape juice significantly increased HDL--the good cholesterol--and significantly lowered two markers of inflammation in people with stable coronary artery disease, according to results of a study presented in the November issue of the journal Arteriosclerosis, Thrombosis and Vascular Biology. "In addition to HDL levels increasing, we saw significant decreases in the production of superoxide, a free radical, and soluble CD40 ligand, an inflammatory marker about which there is growing interest," explains Jane E. Freedman, M.D., Associate Professor of Medicine and Pharmacology, Boston University School of Medicine and an author of the study. "Platelet release of soluble CD40 ligand is thought to contribute to the development of atherosclerosis and vascular inflammation.

We have seen in previous studies of healthy subjects that drinking grape juice decreases superoxide production and inhibits platelet aggregation, yet its impact on the inflammatory properties of platelets had not been previously studied. The soluble CD40 ligand information is new and particularly interesting, given the growing interest in the link between this inflammatory marker and cardiovascular disease."


The positive increase in HDL levels is also noteworthy, according to Freedman. Historically, HDL increases have been linked to drinking red wine and attributed to the alcohol found in the wine. Given that Concord grape juice does not contain alcohol, researchers may now be looking more closely at the polyphenolic compounds found in both wine and grape juice as potential contributors to this effect.

"There has been great interest in the possible benefits of drinking red wine for people with cardiovascular disease," notes Freedman. "But it has been offset, to a certain extent, by concerns about promoting alcohol consumption. This has led to the exploration of non-alcoholic grape products. In the past, we have seen that Concord grape juice has shown strong antioxidant and platelet-inhibitory effects. This is the first study to show its positive effect on soluble CD40 ligand, an emerging marker of cardiovascular inflammation, even in subjects on a daily aspirin regimen."

The double blind, placebo-controlled study looked at 20 subjects, with a mean age of 63 years, who had previously been diagnosed with coronary artery disease and were on standard medications, including aspirin. "Because the patients were already on aspirin therapy, we didn’t see the significant platelet inhibition we typically get in subjects drinking the grape juice. This is not surprising, however, given aspirin’s potent effect on platelets."

Freedman cautions that her study is preliminary and that more work needs to be done in this area. Nonetheless, she notes that consumption of purple grape juice may suppress inflammatory indices that have been recently linked to cardiovascular disease.

The study comes on the heels of the release of the new USDA proanthocyanidin database in which purple grape juice made from Concord grapes tested higher in total proanthocyanidins than any other beverage tested on a per serving basis, including red wine, tea, cranberry juice cocktail and apple juice. Proanthocyanidins, a subset of polyphenols, are natural plant compounds that function as antioxidants and that have been linked to good health in a variety of ways.

Julie McQuain | EurekAlert!

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>